A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.

Details

Ressource 1Download: serval:BIB_686F0B905551.P001 (593.55 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_686F0B905551
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.
Journal
Human Molecular Genetics
Author(s)
Forlino A., Piazza R., Tiveron C., Della Torre S., Tatangelo L., Bonafè L., Gualeni B., Romano A., Pecora F., Superti-Furga A., Cetta G., Rossi A.
ISSN
0964-6906[print], 0964-6906[linking]
Publication state
Published
Issued date
03/2005
Volume
14
Number
6
Pages
859-871
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
Mutations in the diastrophic dysplasia sulfate transporter (DTDST or SLC26A2) cause a family of recessively inherited chondrodysplasias including, in order of decreasing severity, achondrogenesis 1B, atelosteogenesis 2, diastrophic dysplasia (DTD) and recessive multiple epiphyseal dysplasia. The gene encodes a widely distributed sulfate/chloride antiporter of the cell membrane whose function is crucial for the uptake of inorganic sulfate, which is needed for proteoglycan sulfation. To provide new insights in the pathogenetic mechanisms leading to skeletal and connective tissue dysplasia and to obtain an in vivo model for therapeutic approaches to DTD, we generated a Dtdst knock-in mouse with a partial loss of function of the sulfate transporter. In addition, the intronic neomycine cassette in the mutant allele contributed to the hypomorphic phenotype by inducing abnormal splicing. Homozygous mutant mice were characterized by growth retardation, skeletal dysplasia and joint contractures, thereby recapitulating essential aspects of the DTD phenotype in man. The skeletal phenotype included reduced toluidine blue staining of cartilage, chondrocytes of irregular size, delay in the formation of the secondary ossification center and osteoporosis of long bones. Impaired sulfate uptake was demonstrated in chondrocytes, osteoblasts and fibroblasts. In spite of the generalized nature of the sulfate uptake defect, significant proteoglycan undersulfation was detected only in cartilage. Chondrocyte proliferation and apoptosis studies suggested that reduced proliferation and/or lack of terminal chondrocyte differentiation might contribute to reduced bone growth. The similarity with human DTD makes this mouse strain a useful model to explore pathogenetic and therapeutic aspects of DTDST-related disorders.
Keywords
Animals, Anion Transport Proteins, Carrier Proteins/genetics, Carrier Proteins/metabolism, Disease Models, Animal, Humans, Membrane Transport Proteins, Mice, Mice, Transgenic, Osteochondrodysplasias/genetics, Osteochondrodysplasias/metabolism, Phenotype
Pubmed
Web of science
Open Access
Yes
Create date
21/01/2008 12:50
Last modification date
25/09/2019 6:09
Usage data